Effective 1-shot vaccination of newborns moves closer to reality
from Boston Children's Hospital via Infection Control Today
Newborns are highly vulnerable to infections and don't respond optimally to most vaccines because their young immune systems typically mount weak antibody responses. Now, researchers at Boston Children's Hospital report achieving strong vaccine responses in newborn animals, including monkeys — the final preclinical model before human trials — by adding compounds known as adjuvants that boost the immune response.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063